Intestinal Failure, Low Muscle Mass
Conditions
Keywords
Chronic Intestinal Failure, Low Muscle Mass, Resistance Training, Appendicular Skeletal Muscle Mass Index, Physical Function
Brief summary
This single-center, prospective, four-arm randomized controlled trial will enroll 72 adults with chronic intestinal failure and low muscle mass. All participants will receive standardized basic nutritional support and will be randomly assigned to one of four groups: usual care, whey protein supplementation, resistance training, or whey protein supplementation combined with resistance training. Participants assigned to whey protein supplementation will receive 20 g of whey protein daily for 6 weeks. Participants assigned to resistance training will complete moderate-intensity resistance exercises for approximately 30 minutes, 3 to 5 times per week, for 6 weeks. Participants in the combined group will receive both interventions. Body composition, appendicular skeletal muscle mass index, phase angle, handgrip strength, 6-meter walking speed, laboratory indicators, and quality of life will be assessed at baseline, week 6, and week 8. The study aims to evaluate the effectiveness and safety of whey protein supplementation and resistance training, alone or in combination, for improving muscle mass and physical function in patients with chronic intestinal failure.
Interventions
Participants will receive standardized basic nutritional support and 20 g of whey protein orally once daily for 6 weeks.
Participants will perform moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks, in addition to standardized basic nutritional support.
Sponsors
Study design
Intervention model description
This is a four-arm, parallel-group randomized controlled trial evaluating whey protein supplementation and resistance training, each alone and in combination, compared with usual care.
Eligibility
Inclusion criteria
1. Patients with chronic intestinal failure and low muscle mass. 2. Willing to participate in the study and provide written informed consent. 3. Able to complete the assigned 6-week intervention and the assessments at baseline, week 6, and week 8.
Exclusion criteria
1. Known allergy to whey protein. 2. Severe renal dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Appendicular Skeletal Muscle Mass Index | Baseline, Week 6, and Week 8 |